Abstract
Background
It has well known that, compared to normal cells, tumor cells have a different manner of energy metabolism, which influences the sensitivity of radiotherapy (RT). However, whether inhibition of glycolysis enhances the efficacy of radiotherapy is a matter of debate in oral squamous cell carcinoma (OSCC). The aim of this study was to characterize whether the combination of radiotherapy with the glucose inhibitor 2-deoxy-D-glucose (2-DG) affected DNA repair kinetics.
Methods
To compare the synergistic effect of 2-DG, we examined the cell survival after treatment with radiation, 2-DG and a combination of the two in 5 OSCC cell lines and one lip fibroblast cell line, determined using clonogenic survival assay. Changes in the protein levels of DNA repair kinetics such as PARP, Rad51 and Ku-70 were analyzed by western blotting. Then, using one of the 5 OSCC cell lines, we assessed the inhibition of xenograft tumor growth in vivo.
Results
We found that 2-DG with radiation induced significant inhibition of cell proliferation in cell line SAS (p<0.01, one-way ANOVA). Radiation treatment was associated with decreased expression of the DNA repair markers. In additional, combinational treatment with 2-DG and radiation significantly inhibited the xenograft tumor growth compared to the control (p < 0.05), and treatment with 2-DG or radiation alone.
Conclusions
Our study suggests that 2-DG has synergistic cytotoxic effects when combined with radiotherapy, which might lead to the design of an effective metabolic target therapy in vitro and in vivo.
This article is protected by copyright. All rights reserved.
http://ift.tt/2t0yWr3
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου